For each neuropsychiatric syndrome, the authors selected multiple published studies that incorporated patient and healthy control groups and subjected the data from these studies to meta-analysis to look for the effect magnitude and sensitivity of specific tests. The results of their efforts are reported for 11 syndromes: dementia of the Alzheimer's type, frontotemporal dementia, primary progressive aphasia, progressive supranuclear palsy, Parkinson's disease, Huntington's disease, multiple sclerosis, major depressive disorder, schizophrenia, obsessive-compulsive disorder, and mild traumatic brain injury.